Elder Pharmaceuticals Ltd.

Zydus Lifesciences (including its subsidiaries, together referred to as ‘Zydus’), an innovation driven global lifesciences company has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its formulations manufacturing facility in Moraiya, near Ahmedabad, India. The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI). The USFDA had inspected the facility from July 26 to August 05, 2022 which concluded with four observations. The USFDA has indicated that the inspection is closed.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.